Nanotechnology in Drug Delivery

Detalles Bibliográficos
Autor Corporativo: SpringerLink (Online service)
Otros Autores: de Villiers, Melgardt M. (Editor ), Aramwit, Pornanong. (Editor ), Kwon, Glen S. (Editor )
Formato: eBook
Lenguaje:English
Publicado: New York, NY : Springer New York : Imprint: Springer, 2009.
Edición:1st ed. 2009.
Colección:Biotechnology: Pharmaceutical Aspects ; X
Materias:
Acceso en línea:https://doi.org/10.1007/978-0-387-77667-5
Tabla de Contenidos:
  • Fundamentals of Nanotechnology in Drug Delivery
  • Physicochemical Principles of Nanosized Drug Delivery Systems
  • Block Copolymer Synthesis for Nanoscale Drug and Gene Delivery
  • Supercritical Fluid Technology for Nanotechnology in Drug Delivery
  • Nanotubes, Nanorods, Nanofibers, and Fullerenes for Nanoscale Drug Delivery
  • Drug Loading into and In Vitro Release from Nanosized Drug Delivery Systems
  • Nanotechnology-Based Biosensors in Drug Delivery
  • Biopharmaceutical, Physiological, and Clinical Considerations for Nanotechnology in Drug Delivery
  • Nanomaterials and Biocompatibility: BioMEMS and Dendrimers
  • Nanomaterials and Biocompatibility: Carbon Nanotubes and Fullerenes
  • Factors Controlling Pharmacokinetics of Intravenously Injected Nanoparticulate Systems
  • Controlled Release and Nanotechnology
  • Nanotechnology for Intracellular Delivery and Targeting
  • Nanotechnology for the Delivery of Small Molecules, Proteins and Nucleic Acids
  • Nano-sized Advanced Delivery Systems as Parenteral Formulation Strategies for Hydrophobic Anti-cancer Drugs
  • Engineering of Amphiphilic Block Copolymers for Drug and Gene Delivery
  • PAMAM Dendrimers as Nanoscale Oral Drug Delivery Systems
  • Nanoemulsions for Intravenous Drug Delivery
  • Nanotechnology for Cancer Chemotherapy
  • Nanotechnology for Cancer Vaccine Delivery
  • Stimuli-Sensitive Nanotechnology for Drug Delivery
  • A Look to the Future of Nanotechnology in Drug Delivery
  • Nanotechnology in Drug Delivery: Past, Present, and Future
  • Nanotechnology in Drug Development and Life Cycle Management
  • Nanopharmaceuticals: Challenges and Regulatory Perspective.